RDY Related StreetInsider.com Reports
-
Dr. Reddy's (RDY) Founder & Chairman Passes Away
-
Transcept (TSPT) Notified of ANDA Filing for Generic Intermezzo by Dr. Reddy's (RDY)
-
BofA/Merrill Lynch Downgrades Dr. Reddy's Laboratories (RDY) to Neutral
-
Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.40
-
Credit Suisse Upgrades Dr. Reddy's Laboratories (RDY) to Outperform
-
Cowen Starts Dr. Reddy's Laboratories (RDY) at Outperform
-
Time to Buy India Stocks? Goldman Sachs Says 'Yes'
-
Dr. Reddy’s (RDY) Names Umang Vohra as CFO
-
Dr. Reddy’s (RDY) Launches SILDENAFIL TABLETS
-
Dr. Reddys Labs (RDY) Posts Improved Q2 EPS of 50c/Share
-
Dr. Reddys Labs (RDY) Posts Stronger Q1 EPS of 0.40
-
Trading Radar for 07/19: Microsoft (MSFT), Google (GOOG), Verizon (VZ), Morgan Stanley (MS), Chipotle (CMG) Report
-
Dr. Reddy’s Labs (RDY), Merck Serono Enter Biosimilar Compound Development Agreement
-
Dr. Reddy’s Labs (RDY) Launches Generic OTC Prevacid (NVS)
-
Dr. Reddy’s Labs (RDY) Launches Generic Plavix Tabs (SNY)
-
Dr. Reddys Labs (RDY) Reports Flat Q4 EPS of $0.40
-
Trading Radar for 05/11: Gordmans (GMAN), Dr. Reddys (RDY), Cache (CACH), Osiris Therapeutics (OSIR) Report
-
Credit Suisse Downgrades Dr. Reddy's Laboratories (RDY) to Neutral
-
Dr. Reddys Labs (RDY) Reports Q3 Earnings of $0.60
-
Trading Radar for 02/03: Tyson Foods (TSN), Clorox (CLX), Moneygram (MGI), BEAM (BEAM) Report
-
Dr. Reddy’s Laboratories (RDY) Comments on Recent Media Reports
-
Morgan Stanley Names Dr. Reddy's (RDY) 'Long Research Tactical Idea'
-
Teva (TEVA), Dr. Reddy's (RDY) Launch Generic Zyprexa Tabs
-
Dr. Reddys Laboratories Ltd. (RDY) Reports Q2 Earnings of $0.40
-
Dr. Reddy’s (RDY) Launches Generic EXELON in U.S.
-
Pfizer (PFE) May Get Several More Months of Lipitor Exclusivity
-
Dr. Reddy’s (RDY) Initiates DRL-17822 Dosing in Patients with Type II Dyslipidemia
-
Dr. Reddy’s Labs (RDY) Announces Settlement Agreement Related to Lipitor with Pfizer (PFE)
-
Dr. Reddy’s (RDY) to Acquire Prescription Portfolio from JB Chemicals in Certain Regions
-
Dr. Reddys Labs (RDY) Reports Q1 Earnings of $0.35, Stronger Y/Y
-
Trading Radar for 07/19: Intel (INTC), eBay (EBAY), Qualcomm (QCOM), U.S. Bancorp (USB), Xilinx (XLNX) Report
-
Dr. Reddy’s (RDY) Launches Generic LEVAQUIN in U.S.
-
U.S. FDA Approves First Generic Version of Levaquin (MYL) (RDY) (TEVA) (AKRX)
-
Dr. Reddy’s Laboratories (RGY) Receives Warning Letter from USFDA
-
Dr. Reddy’s (RDY) Lauches Three New Generics in U.S.
-
Dr. Reddy\'s Laboratories Ltd. (RDY) Posts Stronger Q4 Results
-
Trading Radar for 05/13: Celsion (CLSN), Agilent (A) Hooper Holmes (HH), Crude Carriers (CRU) Report
-
POZEN (POZEN), AstraZeneca (AZN) File Suit Against Dr. Reddy's (RDY)
-
Dr. Reddy’s (RDY) Launches Generic Allegra (SNY)
-
Valeant (VRX), Dr. Reddy's (RDY) Unit Agree to Collaboration to Market Cloderm in US
-
Dr. Reddy’s (RDY) Launches Generic Xyzal in U.S.
-
Dr. Reddy's Labs (RDY) Updates on Generic Allegra D24 Litigation (SNY, AMRI)
-
Dr. Reddy's Laboratories Ltd. (RDY) sees upside action.
-
Dr. Reddy\'s Labs (RDY) Swings to Q3 Profit
-
Trading Radar for 01/25: Verizon (VZ), 3M (MMM), Yahoo! (YHOO), RF Micro (RFMD), Juniper Networks (JNPR), Altera (ALTR) Report
-
Dr. Reddy’s (RDY) Launches Generic Protonix Tabs
-
GlaxoSmithKline (GSK) to Transfer U.S. Oral Penicillin Portfolio and Facility to Dr. Reddy's Labs (RDY)
-
Dr. Reddy's Laboratories Ltd. (RDY) Posts Stronger Q2 Results
-
Dr. Reddy’s Labs (RDY) To Launch Generic Prevacid in the U.S.
-
Dr. Reddy's (RDY) Shares Rising Following BofA Merrill's Two Notch Upgrade
Back to RDY Stock Lookup
